Cargando…
Treatment of diabetic retinopathy through neuropeptide Y‐mediated enhancement of neurovascular microenvironment
Diabetic retinopathy (DR) is one of the most severe clinical manifestations of diabetes mellitus and a major cause of blindness. DR is principally a microvascular disease, although the pathogenesis also involves metabolic reactive intermediates which induce neuronal and glial activation resulting in...
Autores principales: | Ou, Kepeng, Copland, David A., Theodoropoulou, Sofia, Mertsch, Sonja, Li, Youjian, Liu, Jian, Schrader, Stefan, Liu, Lei, Dick, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171318/ https://www.ncbi.nlm.nih.gov/pubmed/32141716 http://dx.doi.org/10.1111/jcmm.15016 |
Ejemplares similares
-
Restoring retinal neurovascular health via substance P
por: Ou, Kepeng, et al.
Publicado: (2019) -
Corrigendum to “Restoring retinal neurovascular health via substance P” [Exp. Cell Res. (2019)]
por: Ou, Kepeng, et al.
Publicado: (2019) -
Recent developments of neuroprotective agents for degenerative retinal disorders
por: Ou, Kepeng, et al.
Publicado: (2022) -
Endothelin-1 as a neuropeptide: neurotransmitter or neurovascular effects?
por: Dashwood, Michael R., et al.
Publicado: (2009) -
Unravelling the therapeutic potential of IL-33 for atrophic AMD
por: Clare, Alison J., et al.
Publicado: (2021)